Blood thinner showdown: antiplatelets vs anticoagulants for neck artery tears
NCT ID NCT07639892
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two types of blood thinners—antiplatelet drugs (like aspirin) and anticoagulants (like warfarin)—in 1100 people who have a torn neck artery causing a stroke or mini-stroke. The goal is to see which strategy better prevents another stroke, major bleeding, or death within 90 days. Participants are randomly assigned to one treatment group and followed for a year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Antiplatelet drugs (aspirin, clopidogrel) or anticoagulant drugs (warfarin, apixaban, rivaroxaban, dabigatran, edoxaban)
What this could lead to
If it works, this could show which drug strategy is safer and more effective at preventing strokes and major bleeding after a neck artery tear.
What could go wrong
This trial hasn't started yet, and results may not show a clear winner. Both drug types carry bleeding risks, and individual responses vary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL ARTERY DISSECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.